GTx Presents Preclinical Study Results Demonstrating That Capesaris Chronic Treatment Does Not Cause Gynecomastia in Male Primates

GTx, Inc. GTXI announced the presentation today of results of a preclinical study demonstrating that Capesaris treatment achieved and maintained castration over the entire 9 month study without evidence of gynecomastia in male cynomolgus monkeys. The data were presented at the Annual Meeting of the American Urological Association.